medigraphic.com
Instituto Nacional de Salud Pública

2026, Number 4

<< Back Next >>

salud publica mex 2026; 68 (4)

Factors associated with drug use among individuals with and without dependence: analysis of Encodat 2025

Bustos-Gamiño MN, García-Quevedo LR, Fleiz-Bautista C, Ortiz A, Robles R, Audiffred-Jaramillo RI

Language: Spanish
References: 22
Page: 323-332
PDF size: 281.61 Kb.


ABSTRACT

Objective. To describe sociodemographic, mental health, and drug use–related factors associated with past-year drug use among individuals with and without dependence. Materials and methods. A total of 692 Mexican individuals aged 12- 65 years who reported substance use during the 12 months prior to Encuesta Nacional de Consumo de Drogas, Alcohol y Tabaco 2025 participated in the study. Results. Seventeen percent met criteria for drug dependence. The factors most strongly associated with dependence were drug use through high-risk routes of administration (aPR= 5.13, 95%CI: 1.65,15.94); use of three or more drugs (aPR= 6.73, 95%CI: 4.15,10.93), and having two or more mental health problems (aPR= 3.69, 95%CI: 1.93,7.06). Conclusion. These findings underscore the need for prevention actions and programs aimed at delaying the age of onset, strengthening the implementation of early interventions and harm reduction strategies targeted at populations with current substance use, and promoting treatment models that incorporate comprehensive approaches to substance use disorders and mental health.


REFERENCES

  1. United Nations Office on Drugs and Crime. World drug report 2025. United Nations Office on Drugs and Crime, 2025. http://doi.org/10.18356/9789211594850

  2. World Health Organization. Global status report on alcohol andhealth and treatment of substance use disorders. Ginebra: WHO, 2024[citado abril 2026]. Disponible en: https://www.who.int/publications/i/item/9789240096745

  3. Martinez R, Zapata MA, Tausch A, Lange S, Russell C, Hennis A, Oliveirae Souza R. The rising burden of drug use disorders in the Americas, 2000-2021. Rev Panam Salud Publica. 2025;49:e132. http://doi.org/10.26633/RPSP.2025.132

  4. Belfiore CI, Galofaro V, Cotroneo D, Lopis A, Tringali I, Denaro V,Casu M. A multi-level analysis of biological, social, and psychologicaldeterminants of substance use disorder and co-occurring mental healthoutcomes. Psychoactives. 2024;3(2):194-214. https://doi.org/10.3390/psychoactives3020013

  5. Mefodeva V, Carlyle M, Walter Z, Chan G, Hides L. Polysubstanceuse in young people accessing residential and day-treatment servicesfor substance use: substance use profiles, psychiatric comorbidity andtreatment completion. Addiction. 2022;117(12):3110-20. https://doi.org/10.1111/add.16008

  6. Gossop M, Griffiths P, Powis B, Strang J. Gravedad de la dependenciay vía de administración de heroína, cocaína y anfetaminas. Br J Addict.1992;87(11):1527-36. https://doi.org/10.1111/j.1360-0443.1992.tb02660.x

  7. Martínez-Mota L, Jiménez-Rubio G, Hernández-Hernández OT, Páez-Martínez N. Tipos de violencia en la infancia que inciden en el abuso ydependencia de cannabis entre adolescentes: una revisión sistemáticay metaanálisis. Adicciones. 2020;32(1):63-76. https://doi.org/10.20882/adicciones.1050

  8. Organización Mundial de la Salud. Clasificación Internacional deEnfermedades, 11.a Revisión (CIE-11). Ginebra: OMS, 2022 [citado abril,2026]. Disponible en: https://icd.who.int/es/

  9. Medina-Mora ME, Robles R. How the ICD-11 and the CDDR addressthe public health dimensions of substance use. World Psychiatry.2024;23(3):449-51. https://doi.org/10.1002/wps.21252

  10. Castaldelli-Maia JM, Bhugra D. Analysis of global prevalence of mentaland substance use disorders within countries: focus on sociodemographiccharacteristics and income levels. Int Rev Psychiatry. 2022;34(1):6-15.https://doi.org/10.1080/09540261.2022.2040450

  11. Ronzani TM, Pereira TS, Castro JB, Dimenstein M. Social determinantsand drug dependence: Systematic review of literature. Psicol Teor Pesqui.2023;39:e39407. https://doi.org/10.1590/0102.3772e39407.en

  12. Dávila-Cervantes CA. The evolving burden of drug use disorders inMexico: Secondary data analysis from the global burden of disease study2021. Drug Alcohol Depend. 2026;280:113061. https://doi.org/10.1016/j.drugalcdep.2026.113061

  13. Comisión Nacional de Salud Mental y Adicciones, Instituto Nacionalde Psiquiatría Ramón de la Fuente Muñiz e Instituto Nacional de SaludPública. Encuesta Nacional de Consumo de Drogas, Alcohol y TabacoEncodat 2025. México: Secretaría de Salud/Instituto Nacional de SaludPública [citado febrero, 2026]. Disponible en: https://encuestas.insp.mx/repositorio/encuestas/ENCODAT2025/informes.php

  14. Comisión Nacional de Salud Mental y Adicciones, Instituto Nacionalde Psiquiatría Ramón de la Fuente Muñiz, Instituto Nacional de SaludPública. Methodology of the 2025 National Survey on Drug, Alcohol, andTobacco Consumption. Salud Publica Mex. 2025;67(5):515-22. https://doi.org/10.21149/17295

  15. Instituto Nacional de Estadística y Geografía. Guía de diseño de lamuestra para encuestas. Fase de diseño de la norma técnica del procesode producción de información estadística y geográfica. México: Inegi, 2024[citado abril, 2026]. Disponible en: https://www.inegi.org.mx/contenidos/infraestructura/aseguramiento/doc/guia_de_diseno_de_la_muestra_para_encuestas.pdf

  16. Pregibon D. Goodness of link tests for generalized linear models.JSTOR. 1980;29(1):14-5. https://doi.org/10.2307/2346405

  17. Swimmer KR, Sandelich S. Substance use disorder. Emerg Med ClinNorth Am. 2023;42(1):53-67. https://doi.org/10.1016/j.emc.2023.06.023

  18. Font-Mayolas S, Calvo F. Polydrug definition and assessment: The stateof the art. Int J Environ Res Public Health. 2022;19(20):13542. https://doi.org/10.3390/ijerph192013542

  19. Scoppetta O, Avendaño-Prieto BL, Cassiani-Miranda C. Individualfactors associated with the consumption of illicit substances: a reviewof reviews. Rev Colomb Psiquiatr. 2022;51(3):206-17. https://doi.org/10.1016/j.rcpeng.2022.08.002

  20. Vasilenko SA, Evans-Polce RJ, Lanza ST. Age trends in rates of substanceuse disorders across ages 18-90: differences by gender and race/ethnicity. Drug Alcohol Depend. 2017;180:260-4. https://doi.org/10.1016/j.drugalcdep.2017.08.027

  21. Hamaoui J, Pocuca N, Ditoma M, Héguy C, Simard C, Aubin R, et al.Age of onset of cannabis use and substance use problems: A systematicreview of prospective studies. Addict Behav. 2025;163:108259. https://doi.org/10.1016/j.addbeh.2025.108259

  22. Volkow ND, Blanco C. Substance use disorders: a comprehensiveupdate of classification, epidemiology, neurobiology, clinical aspects,treatment and prevention. World Psychiatry. 2023;22(2):203-29. https://doi.org/10.1002/wps.21073




2020     |     www.medigraphic.com